noad

Bioprogress the Next Ten Bagger?

Bioprogress stock quotes

Bioprogress stock charts

Follow this thread / related threads


poorold - Sun, 28 Dec 03 :

Hmmm, if the following is any indication, then BSE as a topic of conversation in the US is only beginning to get started:

from an article today in a Boston newspaper.

"There is still, though, the simple fact that no cases of BSE or nvCJD have ever been diagnosed in the US. Right? Well, maybe. Some mad-cow specialists say the problem is that the United States has not been inspecting cattle in anywhere near the numbers or with the rigor that British and European authorities now do, meaning that cases of BSE could be slipping by. As for the lack of any human cases, there is at least some reason to believe that there are, in fact, tens of thousands of cases ? many of them sitting right in front of us when we visit the nursing home.

In the 1990s, researchers at Yale University and the University of Pittsburgh studied autopsy results of people who had died of Alzheimer's disease. Although their sample sizes were small, the results were chilling: somewhere between eight and 13 percent were found to have actually had CJD rather than Alzheimer's . That's far more than the 250 or so cases that would be statistically expected of "classic," or naturally occurring, CJD, meaning that a more likely explanation would be the consumption of contaminated meat.

That would also fit with the decades-long incubation period for CJD and nvCJD. According to the Web site of the Alzheimer's Association, approximately four million Americans have Alzheimer's ? about 10 percent of those who are 65 or older, and nearly half of those who are 85 or older. As Sheldon Rampton and John Stauber wrote in their book Mad Cow U.S.A.: Could the Nightmare Happen Here? (Common Courage, 1997), "If the true number of CJD cases in the United States turns out to be 40,000 instead of 250, the implications for human health would be severe. It could mean that a deadly infectious dementia akin to Britain's problem has already entered the U.S. population. And since CJD has an invisible latency period of up to 40 years in humans, 40,000 cases could be just the beginning of something much larger."


Bioprogress Stock Charts :

Bioprogress Historic Stock ChartBioprogress Intraday Stock Chart
Bioprogress - Historic Stock ChartBioprogress - Historic Stock Chart
Search for a stock: 



By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Affiliate Scheme
Copyright©1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy

43 site:2us *** bprg081122 23:42 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )